Attenuation of dextran sodium sulphate induced colitis in matrix metalloproteinase-9 deficient mice

Alfredo Santana1, Carlos Medina, Maria-Cristina Paz-Cabrera

  • 1Gastroenterology Department and Research Unit, Hospital Universitario de Canarias, Tenerife, Spain.

Abstract

Insights

Matrix metalloproteinase-9 (MMP-9) plays a key role in dextran sodium sulphate (DSS) induced colitis. MMP-9 deficiency significantly reduces intestinal epithelial damage and inflammation in this colitis model.

Area of Science:

  • Gastroenterology
  • Immunology
  • Molecular Biology

Background:

  • Inflammatory bowel disease (IBD) pathogenesis involves complex interactions between the immune system and the intestinal epithelium.
  • Matrix metalloproteinases (MMPs) are enzymes implicated in tissue remodeling and inflammation, but their specific role in colitis requires further elucidation.

Purpose of the Study:

  • To investigate the role of matrix metalloproteinase-9 (MMP-9) in epithelial damage during dextran sodium sulphate (DSS)-induced colitis in mice.
  • To determine if MMP-9 is a critical mediator of intestinal injury in this experimental colitis model.

Main Methods:

  • Comparison of MMP-9-deficient and wild-type mice subjected to DSS-induced colitis.
  • Assessment of MMP-9 and MMP-2 activity using zymography and Western blot in colonic tissue and peripheral blood polymorphonuclear leukocytes (PMNs).
  • Measurement of tissue inhibitor of metalloproteinases (TIMPs) and colonic mucosal lesions via microscopic examination.

Main Results:

  • MMP-9 activity was significantly elevated in wild-type mice during DSS colitis but absent in MMP-9-deficient mice.
  • Tumor necrosis factor-alpha (TNF-alpha) upregulated MMP-9 production in intestinal epithelial cells.
  • Mice lacking MMP-9 exhibited significantly reduced intestinal epithelial injury and attenuated colitis severity compared to wild-type controls.

Conclusions:

  • DSS-induced colitis is markedly attenuated in the absence of MMP-9.
  • MMP-9 plays a significant role in modulating intestinal injury during DSS colitis.
  • Inhibition of MMP-9 may represent a therapeutic strategy for reducing inflammation in colitis.

Related Concept Videos